PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+46.0%
5Y CAGR+63.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+46.0%/yr
Annual compound
5Y CAGR
+63.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
11.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 277.22% |
| 2024 | -718.18% |
| 2023 | 18.52% |
| 2022 | 89.02% |
| 2021 | 41.84% |
| 2020 | 23.78% |
| 2019 | 47.49% |
| 2018 | -33.97% |
| 2017 | 34.74% |
| 2016 | 47.68% |